| Code | 65911 | ||||||||||
| MA number | EU/1/98/096/023 | ||||||||||
| Product Form: | plv ifo 1x100 mg (liek.inj.skl.) | ||||||||||
| MA Status: | E - Valid centralised marketing authorisation | ||||||||||
| Type of procedure: | EU | ||||||||||
| MAH, country: | Merck Sharp & Dohme B.V., Netherland | ||||||||||
| Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 48 | ||||||||||
| Route of admin.: | Intravenous use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 8(3) application |
| MA issued: | 17.02.2009 |
| SmPC + PL: |
European Medicines Agency's database
|
| Dokument: |
DHPC TEMODAL 29 11 2013.pdf
|
| Safety feature | Yes |
| Data update: | 24.03.2023 |
